Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Research Center for Hepatology and Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Hepatology. 2023 Sep 1;78(3):929-942. doi: 10.1097/HEP.0000000000000335. Epub 2023 Mar 13.
Mutations within the precore (PC) and basal core promoter (BCP) regions of the HBV genome are associated with fulminant hepatitis and HBV reactivation. These mutations may enhance viral replication, but little is known about whether they directly induce damage to the liver. We investigated mechanisms of direct cytopathic effects induced by the infection with PC/BCP mutants in the absence of immune response in vitro and in vivo .
Mice with humanized livers and hepatocytes derived from humanized mice were infected with either wild-type or mutant-type PC/BCP HBV, and the HBV replication and human hepatocyte damage were evaluated. HBV proliferated vigorously in mice with PC/BCP-mutant infection, and the severe loss of human hepatocytes with a slight human ALT elevation subsequently occurred only in PC/BCP mutant mice. In PC/BCP mutant infection, the accumulation of HBsAg in humanized livers colocalized with the endoplasmic reticulum, leading to apoptosis through unfolded protein response in HBV-infected hepatocytes. RNA-sequencing revealed the molecular characteristics of the phenotype of PC/BCP mutant infection in a humanized mouse model. Reduced ALT elevation and higher HBV DNA levels in this model are consistent with characteristics of HBV reactivation, indicating that the hepatocyte damage in this model might mimic HBV reactivation followed by hepatocyte damage under immunosuppressive conditions.
PC and BCP mutations were associated with enhanced viral replication and cell death induced by ER stress using HBV infection models. These mutations might be associated with liver damage in patients with fulminant hepatitis or HBV reactivation.
HBV 基因组前核心(PC)和基本核心启动子(BCP)区域的突变与暴发性肝炎和 HBV 再激活有关。这些突变可能会增强病毒复制,但对于它们是否直接导致肝脏损伤知之甚少。我们研究了在体外和体内无免疫反应的情况下,PC/BCP 突变体感染引起的直接细胞病变效应的机制。
用人源化肝脏和源自人源化小鼠的肝细胞感染野生型或突变型 PC/BCP HBV,并评估 HBV 复制和人肝细胞损伤情况。PC/BCP 突变感染的小鼠中 HBV 大量增殖,随后仅在 PC/BCP 突变小鼠中出现严重的人肝细胞丢失和轻微的人 ALT 升高。在 PC/BCP 突变感染中,HBsAg 在人源化肝脏中的积累与内质网共定位,导致感染肝细胞中未折叠蛋白反应的凋亡。RNA 测序揭示了人源化小鼠模型中 PC/BCP 突变感染的表型的分子特征。该模型中 ALT 升高降低和 HBV DNA 水平升高与 HBV 再激活的特征一致,表明该模型中的肝细胞损伤可能模拟免疫抑制条件下 HBV 再激活后的肝细胞损伤。
PC 和 BCP 突变与使用 HBV 感染模型诱导的增强的病毒复制和内质网应激引起的细胞死亡有关。这些突变可能与暴发性肝炎或 HBV 再激活患者的肝损伤有关。